Literature DB >> 20683890

On the limitations of comparative effectiveness research.

Donald B Rubin1.   

Abstract

Mesh：

Year:  2010        PMID： 20683890     DOI： 10.1002/sim.3960

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  19 in total

1.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

2.  Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System.

Authors:  Tze L Lai; Philip W Lavori
Journal:  Stat Biosci       Date:  2011-12

3.  Use of Propensity Scores To Design Observational Comparative Effectiveness Studies.

Authors:  Robert J Glynn
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

4.  Conducting comparative effectiveness research on medications: the views of a practicing epidemiologist from the other Washington.

Authors:  Bruce M Psaty
Journal:  Value Health       Date:  2011-11-09       Impact factor: 5.725

5.  Empirical Treatment Effectiveness Models for Binary Outcomes.

Authors:  Jarrod E Dalton; Neal V Dawson; Daniel I Sessler; Jesse D Schold; Thomas E Love; Michael W Kattan
Journal:  Med Decis Making       Date:  2015-04-07       Impact factor: 2.583

6.  Estimating the average treatment effects of nutritional label use using subclassification with regression adjustment.

Authors:  Michael J Lopez; Roee Gutman
Journal:  Stat Methods Med Res       Date:  2014-11-28       Impact factor: 3.021

7.  Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.

Authors:  Sengwee Toh; Luis A García Rodríguez; Miguel A Hernán
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-06-30       Impact factor: 2.890

Review 8.  Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies.

Authors:  Xiaoxin I Yao; Xiaofei Wang; Paul J Speicher; E Shelley Hwang; Perry Cheng; David H Harpole; Mark F Berry; Deborah Schrag; Herbert H Pang
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

9.  Causal inference in longitudinal comparative effectiveness studies with repeated measures of a continuous intermediate variable.

Authors:  Chen-Pin Wang; Booil Jo; C Hendricks Brown
Journal:  Stat Med       Date:  2014-02-27       Impact factor: 2.373

10.  Different analyses estimate different parameters of the effect of erythropoietin stimulating agents on survival in end stage renal disease: a comparison of payment policy analysis, instrumental variables, and multiple imputation of potential outcomes.

Authors:  David D Dore; Shailender Swaminathan; Roee Gutman; Amal N Trivedi; Vincent Mor
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.